Compare Abbott Laboratories (ABT) vs Bitwise Crypto Industry Innovators ETF (BITQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Bitwise Crypto Industry Innovators ETF — how do they compare? Abbott Laboratories trades at $95.8 (market cap $166.94B), while Bitwise Crypto Industry Innovators ETF trades at $23.5. The key difference: Abbott Laboratories pays a 2.63% dividend while Bitwise Crypto Industry Innovators ETF pays none, and Bitwise Crypto Industry Innovators ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | BITQ | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Crypto-linked |
52-Week High | $136.62 | $30.43 |
52-Week Low | $82.57 | $16.74 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
BITQ trades at $24.83, up 4.37% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. Support is firm near $24, while resistance sits at $25-$26. The ETF's performance remains tied to crypto industry sentiment, with recent news highlighting investor outflows from Bitcoin ETFs amid market volatility. Financial ratios are unavailable, limiting fundamental clarity.
Outlook is cautious due to bearish technicals and sector headwinds. Opportunities exist if crypto markets rebound, but risks include regulatory uncertainty and reliance on volatile underlying assets. Investors should monitor ETF inflows and broader crypto adoption trends for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Bitwise Crypto Industry Innovators ETF
BITQ tracks companies at the forefront of the crypto economy, including miners, equipment suppliers, and financial service providers. It offers indirect exposure to the growth of the broader crypto ecosystem.
Read more on BITQ →
